Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.44 -0.05 (-0.58%)
As of: Nov 11, 2026 · 9:47 AM EST

Syndax Pharmaceuticals (SNDX) Non-Current Assets (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Non-Current Assets of $125.24 million in Q3 2026, up 470.2% from $21.96 million a year earlier and up 337.7% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Non-Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Non-Current Assets of $1.63 million, down 98.7% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $121.76 million in FY2024 (+280.4%), $32 million in FY2023 (+329.6%), $7.45 million in FY2022 (+490.8%) and $1.26 million in FY2021 (-27.9%).
  • The Q3 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2015.
  • On a year-over-year basis, Non-Current Assets rose in five of the last eight quarters, with growth averaging 88.7%.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 787.6% in Q3 2023, against a decline of 98.7% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $28.61 million (Q2 2026), $1.49 million (Q1 2026) and $1.63 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 141.07 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 110.20 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.47 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 34.86 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 159.99 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 125.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 125.24 Mn
Jun 30, 2026 28.61 Mn
Mar 31, 2026 1.49 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 21.96 Mn
Jun 30, 2025 64.47 Mn
Mar 31, 2025 91.96 Mn
Dec 31, 2024 121.76 Mn
Sep 30, 2024 11.00 Mn
Jun 30, 2024 30.89 Mn
Mar 31, 2024 89.13 Mn
Dec 31, 2023 32.00 Mn
Sep 30, 2023 18.25 Mn
Jun 30, 2023 22.26 Mn
Mar 31, 2023 18.32 Mn
Dec 31, 2022 7.45 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 14.15 Mn
Mar 31, 2022 2.17 Mn
Dec 31, 2021 1.26 Mn
API Access

Syndax Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=SNDX&period=max&api_key=YOUR_API_KEY